Elite Health Systems (EHSI) EBITDA Margin (2016 - 2021)
Elite Health Systems (EHSI) has disclosed EBITDA Margin for 11 consecutive years, with 63.81% as the latest value for Q1 2021.
- On a quarterly basis, EBITDA Margin rose 1481.0% to 63.81% in Q1 2021 year-over-year; TTM through Dec 2021 was 8.29%, a 1397.0% decrease, with the full-year FY2021 number at 8.29%, down 1397.0% from a year prior.
- EBITDA Margin was 63.81% for Q1 2021 at Elite Health Systems, up from 52.05% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 63.81% in Q1 2021 to a low of 113.54% in Q4 2018.
- A 5-year average of 16.2% and a median of 31.67% in 2018 define the central range for EBITDA Margin.
- Peak YoY movement for EBITDA Margin: surged 16381bps in 2019, then plummeted -10232bps in 2020.
- Elite Health Systems' EBITDA Margin stood at 60.36% in 2017, then tumbled by -88bps to 113.54% in 2018, then surged by 144bps to 50.27% in 2019, then crashed by -204bps to 52.05% in 2020, then skyrocketed by 223bps to 63.81% in 2021.
- Per Business Quant, the three most recent readings for EHSI's EBITDA Margin are 63.81% (Q1 2021), 52.05% (Q4 2020), and 42.9% (Q3 2020).